One68 Global Capital, LLC Lumos Pharma, Inc. Transaction History

One68 Global Capital, LLC

  • $0
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$3.05 - $9.52 $17,857 - $55,739
-5,855 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$13.61 - $35.91 $79,686 - $210,253
5,855 New
5,855 $209,000

Others Institutions Holding LUMO

# of Institutions
33
Shares Held
2.2M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.4M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track One68 Global Capital, LLC Portfolio

Follow One68 Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One68 Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One68 Global Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email